ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies.
about
α-Cleavage of cellular prion proteinADAM8 as a drug target in pancreatic cancer.Analysis of the dynamic co-expression network of heart regeneration in the zebrafish.The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthmaTranscriptional responses of resistant and susceptible fish clones to the bacterial pathogen Flavobacterium psychrophilumConservation and divergence of ADAM family proteins in the Xenopus genome.N-glycosylation regulates ADAM8 processing and activationADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor proteinmiR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models.ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.ADAM8 in asthma. Friend or foe to airway inflammation?The metalloprotease ADAM8 is associated with and regulates the function of the adhesion receptor PSGL-1 through ERM proteins.Endogenous light scattering as an optical signature of circulating tumor cell clusters.A time-course microarray data analysis reveals consistent dysregulated genes and upstream microRNAs in autoantibody-mediated arthritis.The Effect of ADAM8 on the Proliferation and Apoptosis of Hepatocytes and Hepatoma Carcinoma Cells.
P2860
Q26863324-79C9D787-98F2-4FF6-9282-3CDAC90AE497Q27324447-5975E373-14DD-4E0C-A9FE-2D35C00FAF37Q27349288-8D76E506-7C25-4068-B316-D758D817D2A2Q28587244-B5387053-9FF8-4E02-94A3-EBE3B552F135Q28728536-21034334-79BD-40BF-965B-CDC4717EA4ABQ30432953-266A7729-0181-41B1-A0C6-43B1E9D0090FQ34580432-7FB12EF3-C88E-4F17-920D-66EBBA02C8E6Q35562470-D2E4991F-9934-491F-B557-EC2C3CD6F559Q36759835-06E0F750-D0B5-431E-99CA-F248153D9946Q37125335-AB2AA1E8-D168-44AE-9B44-700066C588D2Q37591124-BA0FC073-F699-41AD-B165-51951233F2D8Q38120280-045FA5CB-82BD-45E6-B577-F55D29A14D9AQ39415242-37089D76-4A53-4242-9522-18A2DF7FC63DQ41537454-7A7FD1ED-FBFB-4108-B352-BA22066C4DCEQ47100328-0A3C5A8D-AF60-467E-8EAB-76389129FFE6Q53826224-A8DB1578-04C2-47EA-9ABB-1C79BD398843
P2860
ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ADAM8/MS2/CD156, an emerging d ...... tory and invasive pathologies.
@en
ADAM8/MS2/CD156, an emerging d ...... tory and invasive pathologies.
@nl
type
label
ADAM8/MS2/CD156, an emerging d ...... tory and invasive pathologies.
@en
ADAM8/MS2/CD156, an emerging d ...... tory and invasive pathologies.
@nl
prefLabel
ADAM8/MS2/CD156, an emerging d ...... tory and invasive pathologies.
@en
ADAM8/MS2/CD156, an emerging d ...... tory and invasive pathologies.
@nl
P2093
P1476
ADAM8/MS2/CD156, an emerging d ...... tory and invasive pathologies.
@en
P2093
Garrit Koller
Jörg W Bartsch
Panagiota Golfi
Silvia Naus
Taheera Ferdous
Uwe Schlomann
P304
P356
10.2174/138161209788682361
P577
2009-01-01T00:00:00Z